Cintex Svcs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CINTEX SVCS, and what generic and branded alternatives to CINTEX SVCS drugs are available?
CINTEX SVCS has two approved drugs.
Summary for Cintex Svcs
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Cintex Svcs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cintex Svcs | DESONIDE | desonide | GEL;TOPICAL | 202470-001 | May 11, 2020 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Cintex Svcs | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 213619-001 | Nov 10, 2020 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
